tiprankstipranks
Trending News
More News >
InnoCan Pharma (INNPF)
OTHER OTC:INNPF
US Market
Advertisement

InnoCan Pharma (INNPF) Income Statement

Compare
13 Followers

InnoCan Pharma Income Statement

Last quarter (Q1 2025), InnoCan Pharma's total revenue was $7.80M, an increase of 15.19% from the same quarter last year. In Q1, InnoCan Pharma's net income was $-582.00K. See InnoCan Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 29.44M$ 13.66M$ 2.56M$ 196.00K$ 8.00K
Gross Profit
$ 26.19M$ 11.98M$ 2.11M$ 121.00K$ 3.00K
Operating Expenses
$ 27.43M$ 8.18M$ 8.37M$ 7.60M$ 4.73M
Depreciation and Amortization
$ 35.00K$ 33.00K$ 35.00K$ 43.00K$ 40.00K
EBITDA
$ 961.00K$ -3.77M$ -3.85M$ -10.04M$ -9.90M
Operating Income
$ -1.25M$ 3.80M$ -6.27M$ -7.48M$ -4.72M
Other Income/Expenses
$ 2.17M$ -7.84M$ 2.38M$ -2.61M$ -5.23M
Pretax Income
$ 919.00K$ -4.03M$ -3.89M$ -10.09M$ -9.95M
Net Income
$ -1.83M$ -4.70M$ -3.89M$ -10.06M$ -15.18M
Per Share Metrics
Basic EPS
$ -0.01$ -0.02$ -0.02$ -0.04$ -0.09
Diluted EPS
$ -0.01$ -0.02$ -0.02$ -0.04$ -0.09
Weighted Average Shares Outstanding
280.04M 257.01M 248.95M 224.54M 162.02M
Weighted Average Shares Outstanding (Diluted)
280.04M 257.00M 248.95M 224.54M 162.02M
Currency in USD

InnoCan Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis